Skip to main content

Browse Clinical Trials (738 trials open to new patients)

Cancer (720 trials open to new patients)

Acute Lymphoblastic Leukemia (18) Acute Myeloid Leukemia (28) Adenocarcinoma (1) Anal Cancer (6) Anal Intraepithelial Neoplasia (1) Anaplastic Oligodendroglioma (1) Astrocytoma (31) Atypical Teratoid Rhabdoid Tumor (1) Basal Cell Carcinoma (2) Benzodiazepine Refractory Status Epilepticus (1) Biliary Tract Cancer (5) Bladder Cancer (29) Bone Cancer (5) Brain and Central Nervous System Tumor (2) Brain Metastases (3) Brain Stem Neoplasm (1) Breast Cancer (81) Cancer, General (37) Cancer Screening (1) Carcinoid Tumor (2) Carcinoma, Intraductal, Noninfiltrating (1) Carcinoma, Transitional Cell (3) Cervical Adenosquamous Carcinoma (4) Cervical Cancer (13) Cholangiocarcinoma (10) Chordoma (1) Choriocarcinoma (3) CNS Tumor (2) Colorectal Cancer (44) Colorectal Tumor (1) Congenital Mesoblastic Nephroma (3) Cutaneous Malignancy (1) Endometrial Cancer (13) Ependymoma (8) Esophageal Cancer (4) Estrogen Receptor Negative (5) Estrogen Receptor Positive (1) Ewing Sarcoma (12) Fallopian Tube Cancer (10) Fibrolamellar Carcinoma (1) Fibrosarcoma (1) Ganglioneuroblastoma (3) Gastroesophageal Junction Adenocarcinoma (3) Gastrointestinal Cancer Metastatic (1) Germ Cell Tumor (10) Glioblastoma (26) Glioma (54) Gliosarcoma (3) Head and Neck Cancer (29) Head and Neck Squamous Cell Carcinoma (22) Head and Neck Tumor (5) Hematological Malignancy (2) Hepatic Cancer (1) Hepatocellular Cancer (2) HER2 (16) Hodgkin's Lymphoma (6) Hormone Receptor Positive (1) Hypopharynx Cancer (1) Immunotherapy (16) Kidney Cancer (31) Langerhans Cell Histiocytosis (9) Laryngeal Cancer (1) Larynx Cancer (1) Leiomyosarcoma (1) Leukemia (63) Lip and Oral Cavity Cancer (1) Liposarcoma (1) Liver Cancer (31) Lung Cancer (96) Lung Tumor (2) Lymphoma (76) Malignant Germ Cell Neoplasm (1) Malignant Neoplasm (23) Malignant Peripheral Nerve Sheath Tumor (2) Malignant Solid Neoplasm (22) Mantle Cell Lymphoma (6) Medulloblastoma (10) Melanoma (45) Meningioma (1) Merkel Cell Carcinoma (1) Mesothelioma (6) Metastatic Cancer (6) Metastatic Malignant Solid Neoplasm (9) Metastatic Neoplasm (2) Mucinous Adenocarcinoma (1) Multiple Myeloma (20) Nasopharyngeal Cancer (4) Nasopharynx Cancer (1) Neoplasm (6) Neoplasm Metastasis (1) Neoplasms by Site (1) Neuroblastoma (21) Neuroendocrine Tumor (7) Non Hodgkin Lymphoma (31) Non-Small Cell Lung Cancer (67) Nonsquamous Nonsmall Cell Neoplasm of Lung (1) Oligodendroglioma (4) Oral Cavity Cancer (1) Oropharynx Cancer (1) Osteosarcoma (11) Ovarian Cancer (21) Ovarian Clear Cell Adenocarcinoma (3) Ovarian Embryonal Carcinoma (1) Ovarian Mucinous Adenocarcinoma (2) Ovarian Serous Adenocarcinoma (3) Ovarian Tumor (2) Pancreatic Cancer (25) Penile Cancer (2) Peripheral Primitive Neuroectodermal Tumor (5) Peritoneal Cancer (9) Pheochromocytoma (1) Pineal Region Neoplasm (1) Primary Peritoneal Serous Adenocarcinoma (2) Progesterone Receptor Negative (5) Progesterone Receptor Positive (1) Prostate Cancer (69) Refractory Central Nervous System Neoplasm (11) Refractory Malignant Solid Neoplasm (17) Refractory Plasma Cell Myeloma (3) Refractory Tumor (1) Renal Cell Carcinoma (25) Renal Pelvis Cancer (2) Rhabdoid Tumor (9) Rhabdomyosarcoma (11) Salivary Gland Cancer (2) Sarcoma (31) Seminoma (3) Skin Cancer/Melanoma (47) Soft Tissue Sarcoma (13) Solid Cancers (1) Solid Neoplasm (5) Solid Tumor (88) Squamous Intraepithelial Lesion (1) Stomach Cancer (11) Synovial Sarcoma (1) T Cell Lymphoma (6) Teratoma (4) Testicular Cancer (1) Testicular Tumor (1) Thyroid Cancer (8) Thyroid Gland Carcinoma (5) Thyroid Gland Medullary Carcinoma (1) Unresectable Solid Neoplasm (5) Ureter Cancer (3) Ureter Carcinoma (1) Urethra Carcinoma (1) Urethral Cancer (4) Urinary Bladder Tumor (3) Uterine Cancer (3) Vaginal Cancer (2) Waldenstrom Macroglobulinemia (1) Wilms Tumor (9)

Immune System (2 trials open to new patients)

Injuries (1 trials open to new patients)

Metabolic Problems (2 trials open to new patients)

Organ and Tissue Transplant (4 trials open to new patients)

Reproductive Health (3 trials open to new patients)

Surgical Studies (1 trials open to new patients)

Other (236 trials open to new patients)

Absence of Signs or Symptoms (1) Acinar Cell Carcinoma (1) Activating Mutations (1) Acute Promyelocytic Leukemia (1) Adenocarcinoma of the Lung (1) Adenoid Cystic Carcinoma (2) Adnexal Carcinoma (1) Adrenal Cortex Carcinoma (2) Adrenal Gland Pheochromocytoma (1) Adrenocortical Carcinoma (1) Adrenocortical Carcinoma (Part G) (1) Aggressive NHL (a NHL) (1) Aggressive Systemic Mastocytosis (1) ALK Fusion Protein Expression (1) ALK Gene Rearrangement (2) ALK Gene Translocation (1) ALK Positive (1) Anal Basaloid Carcinoma (1) Anal Canal Cloacogenic Carcinoma (1) Anal Canal Neuroendocrine Carcinoma (1) Anal Canal Undifferentiated Carcinoma (1) Antibiotic Allergy (1) Antibiotics (1) Apocrine Carcinoma (1) Appendix Mucinous Adenocarcinoma (1) ARAF Gene Mutation (1) ATM Gene Mutation (1) Automimmune Diseases (1) B Cells--Tumors (1) Barrett's Esophagus (1) BCR-ABL1 Fusion Protein Expression (1) BCR/ABL1 Fusion Protein Negative (1) Bladder Small Cell Neuroendocrine Carcinoma (2) Blood Clot (1) BRAF Gene Mutation (2) BRAF NP_004324.2:p.V600X (1) BRAF V600E Mutation Present (1) BRAF V600K Mutation Present (1) BRAF wt Allele (1) Breast Secretory Carcinoma (1) BRIP1 Gene Mutation (1) Bronchial Neoplasms (2) Cancer of the Stomach (1) Cancer Prevention (1) Carcinoma (1) Carcinoma Breast (1) Carcinoma, Bronchogenic (2) Carcinoma, Ductal, Breast (2) Carcinoma, Pancreatic Ductal (1) Cardiotoxicity (1) Cardiovascular Complication (1) Caregivers (1) Castration Levels of Testosterone (2) CD19 Positive (1) CD20 Negative (1) CD20 Positive (1) Central Nervous System Embryonal Tumor (1) CHEK2 Gene Mutation (1) Chemoembolization, Therapeutic (1) Chest Wall Disease (1) Chronic Lymphocytic Leukemia (12) CNS Malignancies (1) Colon Cancer (9) Cutaneous T-Cell Lymphoma (2) Cytopenia (1) Decision Support Systems, Clinical (1) Deep Vein Thrombosis (1) Deleterious ATM Gene Mutation (1) Deleterious RAD51C Gene Mutation (1) Deleterious RAD51D Gene Mutation (1) Desmoid-Type Fibromatosis (2) Differentiated Thyroid Gland Carcinoma (1) Digestive System Neuroendocrine Neoplasm (1) Digestive System Signs and Symptoms (1) DNA Repair Disorder (1) Dysplasia (1) Dyspnea (1) Eccrine Porocarcinoma (1) EGFR Activating Mutation (2) EGFR Exon 19 Deletion Mutation (3) EGFR Exon 20 Insertion Mutation (1) EGFR NP_005219.2:p.G719X (2) EGFR NP_005219.2:p.L858R (4) EGFR NP_005219.2:p.L861Q (2) EGFR NP_005219.2:p.T790M (4) EGFR T790M Mutation Negative (1) Elevated Alpha-Fetoprotein (1) Elevated PSA (1) Ependymal Tumor (1) ERBB2 Gene Amplification (1) Esophageal Carcinoma (1) Esophageal Neuroendocrine Carcinoma (1) Esophageal Undifferentiated Carcinoma (1) Esophagogastric Junction (1) Esophagogastric Junction Neoplasm (1) Extragonadal Embryonal Carcinoma (1) Extraocular Cutaneous Sebaceous Carcinoma (1) Eyelid Diseases (1) Fatigue (1) FGFR1 Gene Mutation (1) FGFR2 Amplification (1) FGFR2 Gene Mutation (2) FGFR3 Gene Mutation (1) FGFR4 Gene Mutation (1) Fibromyxoid Tumor (1) Gastric Neuroendocrine Carcinoma (1) Gastric Undifferentiated Carcinoma (1) Gastroenteropancreatic Neuroendocrine Carcinoma (1) Gastrointestinal Stromal Tumor (5) Genitourinary Cancer (1) Giant Cell Carcinoma (1) Giant Cell Tumors (1) GNA11 Gene Mutation (2) GNAQ Gene Mutation (2) Hematologic Malignancies (2) Hematologic Neoplasms (1) Hematopoietic and Lymphoid Cell Neoplasm (1) Hematopoietic Cell Transplantation Recipient (3) Hemispheric (1) Hepatic Carcinoma (1) Hepatoblastoma (9) Hepatocellular Carcinoma (28) Hidradenocarcinoma (1) High Risk Myelodysplasia (1) Histiocytic and Dendritic Cell Neoplasm (1) Histiocytic Disorders (1) Histiocytosis (3) HLA-A*0201 Positive Cells Present (2) HNSCC (1) HRAS Gene Mutation (2) HRAS Mutant Tumor (1) Human Papillomavirus (6) Human Papillomavirus Negative (1) Hypercalcemia (1) Hypopharyngeal Carcinoma (1) IDH1 Gene Mutation (1) IDH2 Gene Mutation (1) Infantile Fibrosarcoma (1) Infection (1) Intermediate Grade Lung Neuroendocrine Neoplasm (1) Intestinal Neoplasms (1) Intestinal Neuroendocrine Carcinoma (1) Juvenile Xanthogranuloma (1) Kaposi's Sarcoma (6) Keratoacanthoma (1) Kidney Medullary Carcinoma (1) KRAS Gene Mutation (3) Large Cell Neuroendocrine Carcinoma (1) Lip SCC (1) Locally Advance Pancreatic Ductal Adenocarcinoma (1) Locally Advanced Malignant Solid Neoplasm (3) Locally Advanced Solid Neoplasm (1) Low Grade Lung Neuroendocrine Neoplasm (1) Lung Neuroendocrine Neoplasm (1) Lung Non-Small Cell Cancer (3) Lung Non-Small Cell Carcinoma (3) Lung Non-Squamous Non-Small Cell Carcinoma (1) Lung Sarcomatoid Carcinoma (1) Lung Small Cell Carcinoma (1) Lymphadenopathy (1) Lymphedema (1) Major Salivary Gland Carcinoma (1) Malignancies Except Leukemia (1) Malignancies Multiple (1) Malignancies (1) Malignant Central Nervous System Neoplasm (2) Malignant Neoplastic Disease (1) Malignant Neuroendocrine Carcinoma (Diagnosis) (1) Malignant Odontogenic Neoplasm (1) Malignant Ovarian Brenner Tumor (1) Malignant Sweat Gland Neoplasm (1) Malignant Testicular Sex Cord-Stromal Tumor (1) Malignant Uterine Neoplasm (1) MAP2K1 Gene Mutation (1) MAPK1 Gene Mutation (1) Matched Targeted Therapy (1) MET Fusion Gene Positive (1) Metastasis (1) Metastatic Gastrointestinal Carcinoma (1) Metastatic Penile Carcinoma (1) Metastatic Thyroid Gland Carcinoma (1) Microcystic Adnexal Carcinoma (1) Microsatellite Stable (2) Minimal Residual Disease (1) Mismatch Repair Deficiency (1) Mismatch Repair Protein Proficient (1) MITF Positive (1) Mixed Mesodermal (Mullerian) Tumor (1) Mixed Oligoastrocytoma (3) MMR-deficient Tumors (1) Mucinous Cystadenocarcinoma (1) Mycosis Fungoides (1) Mycosis Fungoides (MF) (1) Myelofibrosis (2) Myeloma (1) Myeloproliferative Neoplasms (4) Narcotic Use (1) Nasal Cavity Adenocarcinoma (1) Nasal Cavity Carcinoma (1) Nasopharyngeal Papillary Adenocarcinoma (1) Nasopharyngeal Undifferentiated Carcinoma (1) Nausea and Vomiting (1) NBN Gene Mutation (1) Neoplasm of Bone (1) Neoplasm of Lung (1) Neoplasms, Colorectal (1) Neoplasms, Nerve Tissue (2) Neoplasms Pancreatic (1) Neuroendocrine Carcinoma (1) Neuroendocrine Neoplasm (2) NF1 Gene Mutation (2) NMYC Gene Amplification (1) Nodule Solitary Pulmonary (1) Non-Melanomatous Lesion (1) Non-Small-Cell Lung (1) Non-urothelial Bladder (1) Non-urothelial Upper Tract (1) NRAS Gene Mutation (2) NRAS wt Allele (1) NTRK1 Fusion Positive (2) NTRK2 Fusion Positive (2) NTRK3 Fusion Positive (2) NY-ESO-1 Positive (1) NY-ESO-1 Positive Tumor Cells Present (1) Oral Cavity Carcinoma (1) Oral Cavity Verrucous Carcinoma (1) Oropharyngeal (p16-Negative) Carcinoma (1) Oropharyngeal Undifferentiated Carcinoma (1) Ovarian Seromucinous Carcinoma (3) Ovarian Serous Tumor (1) Ovarian Undifferentiated Carcinoma (2) p16 Positive Neoplastic Cells Present (1) Paget's Disease (1) PALB2 Gene Mutation (1) Pancreatic Acinar Cell Carcinoma (1) Pancreatic Diseases (1) Pancreatic Ductal Adenocarcinoma (3) Pancreatic Neuroendocrine Carcinoma (1) Papillary Adenocarcinoma (1) Paranasal Sinus Adenocarcinoma (1) Paranasal Sinus Carcinoma (1) Parathyroid Gland Carcinoma (1) Pediatric Cancer (1) Philadelphia Chromosome Positive (2) Pituitary Gland Carcinoma (1) Placental-Site Gestational Trophoblastic Tumor (1) Plasma Cell Myeloma (4) Plasmacytoma (1) Plexiform Neurofibroma (1) Poorly Differentiated Thyroid Gland Carcinoma (2) Positive Lymph Node (1) Postmenopausal (1) Primary Cutaneous Mucinous Carcinoma (1) Prostate Neuroendocrine Neoplasm (1) Prostate Small Cell Carcinoma (2) PSA Level Greater Than or Equal to Two (1) PSA Progression (4) Pseudomyxoma Peritonei (1) Pulmonary Disease (1) RAD51 Gene Mutation (1) Radiation Toxicity (1) Rare Disorder (1) RB1 Positive (1) Rectal Cancer (6) Refractory Cancer (1) Refractory Germ-cell (1) Refractory Hepatoblastoma (3) Refractory Langerhans Cell Histiocytosis (7) Refractory Mycosis Fungoides (1) Refractory Neoplasm (1) Refractory Neurofibromatosis Type 1 (1) Refractory Osteosarcoma (5) Renal Pelvis Carcinoma (1) Renal Pelvis Neoplasms (2) Resistant Cancer (1) Respiratory Tract Neoplasms (2) RET Fusion Positive (1) Richter's Syndrome (2) ROS1 Fusion Positive (1) Salivary Cancer (1) Salivary Gland Neoplasms (2) Sdh (1) Seminal Vesicle Adenocarcinoma (1) Serous Cystadenocarcinoma (1) Sezary Syndrome (1) Signet Ring Cell Carcinoma (1) Sinonasal Carcinoma (1) Skin Basosquamous Cell Carcinoma (1) Small Intestinal Adenocarcinoma (1) SMARCB1 Gene Mutation (1) Spinal Column Tumor (1) Spindle Cell Neoplasm (1) Spiradenocarcinoma (1) Squamous Cell Carcinoma (34) Squamous Intraepithelial Neoplasia (1) Stomach Neoplasms (1) Stromal Neoplasm (1) Surgical Incision (1) Surgical Site Infection (1) Surgical Wound Infection (1) Surgical Wound, Recent (1) Sweat Gland Carcinoma (1) TFE3 Gene Translocation (1) TFEB Gene Translocation (1) Thoracic Neoplasms (2) Thyroid Gland Follicular Carcinoma (2) Thyroid Gland Oncocytic Follicular Carcinoma (1) Thyroid Gland Papillary Carcinoma (2) TP53 wt Allele (2) Tracheal Carcinoma (1) Transitional Cell Carcinoma (30) Trichilemmocarcinoma (1) Trisomy 21 Mosaicism (1) TSC1 Gene Mutation (2) TSC2 Gene Mutation (2) Tumor Types With FGFR2 Gene Fusions (1) Unmethylated MGMT Gene Promoter (1) Unresectable Malignant Solid Neoplasm (1) Ureter Adenocarcinoma (1) Ureter Small Cell Carcinoma (1) Ureteral Neoplasms (2) Urethral Adenocarcinoma (1) Urethral Neoplasms (2) Urologic Neoplasms (2) Uterine Neoplasms (1) Vaginal Adenocarcinoma (2) Vaginal Adenosquamous Carcinoma (1) Vulvar Carcinoma (1)